FLEURY S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.75 BRL | -1.21% |
|
+1.30% | -18.24% |
ETFs positioned on Fleury S.A.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.43% | 2 M€ | -14.14% | ||
| 0.24% | 0 M€ | -1.08% | ||
| 0.02% | 4 M€ | -4.41% | - | |
| 0.01% | 0 M€ | +4.02% | - | |
| 0.00% | 0 M€ | +4.65% | - | |
| 0.00% | 0 M€ | +3.48% | - |
Fleury S.A. specializes in clinical diagnosis, treatment and analysis services.
At the end of 2018, the group operated a network of 187 patient care centers and 23 hospital centers under Fleury, Weinmann, Clínica Felipe Mattoso, a +, Labs a + and Diagnoson a + brands.
Calendar
03:00pm
- Q1 2024 Earnings Call
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
14.75
BRL
Average target price
19.6
BRL
Spread / Average Target
+32.88%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -18.24% | 1.58B | |
| -16.58% | 8.44B | |
| +54.07% | 3.96B | |
| -37.54% | 2.52B | |
| -10.51% | 2.44B | |
| -8.91% | 2.22B | |
| -4.20% | 1.98B | |
| -36.41% | 1.3B | |
| +2.19% | 1.05B | |
| -32.43% | 902M |
- Stock Market
- Equities
- FLRY3 Stock
- Funds and ETFs Fleury S.A.
